Management of antithrombotic therapies in patients scheduled for eye surgery

European Journal of Anaesthesiology

Volumn 30, Issue 8, 2013, Pages 449-454

  Bonhomme, Fanny ^a   Hafezi, Farhad ^a   Boehlen, Françoise ^a   Habre, Walid ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; APIXABAN; CLOPIDOGREL; DABIGATRAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PRASUGREL; THIENOPYRIDINE DERIVATIVE; TICAGRELOR; WARFARIN;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; AORTA VALVE PROSTHESIS; ARTERIAL THROMBOEMBOLISM; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BARE METAL STENT; BLEEDING; BRAIN ISCHEMIA; CATARACT EXTRACTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; DRUG WITHDRAWAL; EYE SURGERY; GLAUCOMA SURGERY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART VALVE PROSTHESIS; HUMAN; HYPHEMA; INTRAOCULAR PRESSURE; LUNG EMBOLISM; MECHANICAL HEART VALVE; MITRAL VALVE PROSTHESIS; PERIOPERATIVE PERIOD; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLASTIC SURGERY; PLATELET REACTIVITY; REOPERATION; STENT THROMBOSIS; STRABISMUS; THROMBOSIS; TRABECULECTOMY; TRANSIENT ISCHEMIC ATTACK; VENOUS THROMBOEMBOLISM; VITRECTOMY; VITREORETINAL SURGERY;

ANTICOAGULANTS; CATARACT EXTRACTION; EYE DISEASES; FIBRINOLYTIC AGENTS; GLAUCOMA; HEMORRHAGE; HUMANS; OPHTHALMOLOGIC SURGICAL PROCEDURES; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; THROMBOEMBOLISM; VITREORETINAL SURGERY;

EID: 84884486775     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328360c442     Document Type: Article

References (42)

1. Benzimra JD, Johnston RL, Jaycock P, et al. The Cataract National Dataset electronic multicentre audit of 55 567 operations: antiplatelet and anticoagulant medications. Eye 2009; 23:10-16.
2. Leaming DV. Practice styles and preferences of ASCRS members: 2003 survey. J Cataract Refract Surg 2004; 30:892-900. (Pubitemid 38501487)
3. El-Hindy N, Johnston RL, Jaycock P, et al. The Cataract National Dataset Electronic Multicentre Audit of 55 567 operations: anaesthetic techniques and complications. Eye 2009; 23:50-55.
4. Katz J, Feldman MA, Bass EB, et al. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2003; 110:1784-1788. (Pubitemid 37025439)
5. Kobayashi H. Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery. J Cataract Refract Surg 2010; 36:1115-1119.
6. Barequet IS, Sachs D, Shenkman B, et al. Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy. J Cataract Refract Surg 2011; 37:1434-1438.
7. Bell AD, Roussin A, Cartier R, et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines. Can J Cardiol 2011; 27 (Suppl A):S1-S59.
8. Kolh P, Wijns W, Danchin N, et al. ESC/EACTS Task Force on Myocardial Revascularization. Guidelines on myocardial revascularization. Eur J Cardiothoracic Surg 2010; 38 (Suppl):S1-S52.
9. Rossini R, Capodanno D, Lettieri C, et al. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am J Cardiol 2011; 107:186-194.
10. Albaladejo P, Marret E, Samama CM, et al. Noncardiac surgery in patients with coronary stents: the RECO study. Heart 2011; 97:1566-1572.
11. Lordkipanidzé M, Diodati JG, Pharand C. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence. Pharmacol Ther 2009; 123:178-186.
12. Sambu N, Warner T, Curzen N. Clopidogrel withdrawal: is there a ?rebound? phenomenon? Thromb Haemost 2011; 105:211-220.
13. D?Ascenzo F, Bollati M, Clementi F, et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including studies, 221 066 patients, and 4276 thromboses. Int J Cardiol 2012. doi:10.1016/j.ijcard.2012.01.080.
14. Garća Rodŕguez LA, Cea Soriano L, Hill C, Johansson S. Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology 2011; 76:740-746.
15. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary-a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2007; 50:1707-1732.
16. The Task Force for Preoperative Cardiac Risk Assessment and Perioperative CardiacManagement in Noncardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery. Eur Heart J 2009; 30:2769-2812.
17. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl):e326S-e350S.
18. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285:2864-2870. (Pubitemid 32537350)
19. Dunn AS, Turpie AGG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163:901-908. (Pubitemid 36522737)
20. Carrel TP, Klingenmann W, Mohacsi PJ, et al. Perioperative bleeding and thromboembolic risk during noncardiac surgery in patients with mechanical prosthetic heart valves: an institutional review. J Heart Valve Dis 1999; 8:392-398. (Pubitemid 29396394)
21. Nouvellon E, Cuvillon P, Ripart J. Regional anesthesia and eye surgery. Anesthesiology 2010; 113:1236-1242.
22. Eriksson A, Koranyi G, Seregard S, Philipson B. Risk of acute suprachoroidal hemorrhage with phacoemulsification. J Cataract Refract Surg 1998; 24:793-800. (Pubitemid 28303018)
23. Ling R, Kamalarajah S, Cole M, et al. Suprachoroidal haemorrhage complicating cataract surgery in the UK: a case control study of risk factors. Br J Ophthalmol 2004; 88:474-477. (Pubitemid 38437862)
24. Kumar N, Jivan S, Thomas P, McLure H. Sub-Tenon?s anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 2006; 32:1022-1025. (Pubitemid 43949463)
25. Jamula E, Anderson J, Douketis JD. Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis. Thromb Res 2009; 124:292-299.
26. Dayani PN, Grand MG. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Arch Ophthalmol 2006; 124:1558-1565. (Pubitemid 44748728)
27. Fu AD, McDonald HR, Williams DF, et al. Anticoagulation with warfarin in vitreoretinal surgery. Retina 2007; 27:290-295. (Pubitemid 46398893)
28. Oh J, Smiddy WE, Kim SS. Antiplatelet and anticoagulation therapy in vitreoretinal surgery. Am J Ophthalmol 2011; 151:934-939.
29. Chandra A, Jazayeri F, Williamson TH. Warfarin in vitreoretinal surgery: a case controlled series. Br J Ophthalmol 2011; 95:976-978.
30. Passemard M, Koehrer P, Juniot A, Bron AM, Creuzot-Garcher C. Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery. Retina 2012; 32:1868-1873.
31. Brown JS, Mahmoud TH. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy. Retina 2011; 31:1983-1987.
32. Cobb CJ, Chakrabarti S, Chadha V, Sanders R. The effect of aspirin and warfarin therapy in trabeculectomy. Eye 2007; 21:598-603. (Pubitemid 46730707)
33. Law SK, Song BJ, Yu F, et al. Hemorrhagic complications from glaucoma surgery in patients on anticoagulation therapy or antiplatelet therapy. Am J Ophthalmol 2008; 145:736-746.
34. Alwitry A, King AJ, Vernon SA. Anticoagulation therapy in glaucoma surgery. Graefes Arch Clin Exp Ophthalmol 2008; 246:891-896.
35. Lewis KG, Dufresne RG Jr. A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery. Dermatol Surg 2007; 34:160-165.
36. Bordeaux JS, Martires KJ, Goldberg D, et al. Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications. J Am Acad Dermatol 2011; 65:576-583.
37. Cook-Norris RH, Michaels JD, Weaver AL, et al. Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation. J Am Acad Dermatol 2011; 65:584-591.
38. Hass AN, Penne RB, Stefanyszyn MA, Flanagan JC. Incidence of postblepharoplasty orbital hemorrhage and associated visual loss. Ophthal Plast Reconstr Surg 2004; 20:426-432. (Pubitemid 39600907)
39. Custer PL, Trinkaus KM. Hemorrhagic complications of oculoplastic surgery. Ophthal Plast Reconstr Surg 2002; 18:409-415. (Pubitemid 35356219)
40. Lip GYH, Durrani OM, Roldan V, et al. Peri-operative management of ophthalmic patients taking antithrombotic therapy. Int J Clin Pract 2011; 65:361-371.
41. Royal College of Anaesthetists and Royal College of Ophthalmologists. Local anaesthesia for ophthalmic surgery; 2012 (http://www.rcoa.ac.uk/node/2272) . Access on 3.13.2013.
42. Sié P, Samama CM, Godier A, et al. Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis And Haemostasis. Arch Cardiovas Dis 2011; 104:669-676.